Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 Oct 23;2(6042):972–975. doi: 10.1136/bmj.2.6042.972

Can phenformin-induced lactic acidosis be prevented?

E A Gale, R B Tattersall
PMCID: PMC1689268  PMID: 974710

Abstract

Although patients taking phenformin are more likely to develop lactic acidosis in the presence of renal, cardiovascular, or hepatic disease, criteria for safe use of the drug are not well established. Eight diabetics died of lactic acidosis in Nottingham in 1972-5 and all were taking phenformin in therapeutic doses. Six had attended the diabetic clinic within a month of their terminal illness. Two patients had appreciable renal impairment and should not have been given phenformin. Four had hypertension and minimal evidence of renal disease, while in two no predisposing factor was identified. There are so many contraindications to the use of phenformin that it is doubtful whether patients on the drug can be monitored adequately. We suggest that phenformin should be withdrawn from general use.

Full text

PDF
972

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assan R., Heuclin C., Girard J. R., LeMaire F., Attali J. R. Phenformin-induced lactic acidosis in diabetic patients. Diabetes. 1975 Sep;24(9):791–800. doi: 10.2337/diab.24.9.791. [DOI] [PubMed] [Google Scholar]
  2. Blumenthal S. A., Streeten D. H. Letter: Phenoformin-related lactic acidosis in a thirty-year-old man. Ann Intern Med. 1976 Jan;84(1):55–56. doi: 10.7326/0003-4819-84-1-55_2. [DOI] [PubMed] [Google Scholar]
  3. Dembo A. J., Marliss E. B., Halperin M. L. Insulin therapy in phenformin-associated lactic acidosis; a case report, biochemical considerations and review of the literature. Diabetes. 1975 Jan;24(1):28–35. doi: 10.2337/diab.24.1.28. [DOI] [PubMed] [Google Scholar]
  4. Dobson H. L. Attempted suicide with phenformin. Diabetes. 1965 Dec;14(12):811–812. doi: 10.2337/diab.14.12.811. [DOI] [PubMed] [Google Scholar]
  5. Fulop M., Hoberman H. D. Phenformin-associated metabolic acidosis. Diabetes. 1976 Apr;25(4):292–296. doi: 10.2337/diab.25.4.292. [DOI] [PubMed] [Google Scholar]
  6. Toghill P. J., Smith P. G., Benton P., Brown R. C., Matthews H. L. Methyldopa liver damage. Br Med J. 1974 Aug 31;3(5930):545–548. doi: 10.1136/bmj.3.5930.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Vinik A. I., Jackson W. P. Lactic acidosis in diabetics. S Afr Med J. 1974 Oct 5;48(48):2021–2026. [PubMed] [Google Scholar]
  8. WALKER R. S., LINTON A. L., THOMSON W. S. Mode of action and side-effects of phenformin hydrochloride. Br Med J. 1960 Nov 26;2(5212):1567–1569. doi: 10.1136/bmj.2.5212.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wise P. H., Chapman M., Thomas D. W., Clarkson A. R., Harding P. E., Edwards J. B. Phenformin and lactic acidosis. Br Med J. 1976 Jan 10;1(6001):70–72. doi: 10.1136/bmj.1.6001.70. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES